Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This is an double-blinded, randomized controlled clinical trial to determine if Venlafaxine
can prevent development of depression in patients undergoing treatment for head and neck
cancer.